SurVaxM Brain Cancer Vaccine
A new clinical research study at Roswell Park, developed by Robert Fenstermaker, MD, and Michael Ciesielski, PhD, will test a first-of-its-kind cancer “vaccine” that may prove effective against many forms of solid-tumor cancers.
SurVaxM Additional Reading
Since this video was produced in September 2012, Drs. Fenstermaker and Ciesielski have made progress in studying the safety and effectiveness of SurVaxM. We encourage you to read the following updates about this promising brain cancer vaccine.